Predictive Oncology Inc. (POAI)
NASDAQ: POAI · Real-Time Price · USD
1.510
+0.030 (2.03%)
Apr 2, 2025, 12:44 PM EDT - Market open

Predictive Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
11513246213
Upgrade
Market Cap Growth
-59.10%-59.10%-44.64%-61.32%382.16%26.38%
Upgrade
Enterprise Value
1255-12218
Upgrade
Last Close Price
1.480.823.296.1319.0414.65
Upgrade
PS Ratio
4.973.377.5116.0443.9410.34
Upgrade
PB Ratio
-53.55-26.981.621.111.554.90
Upgrade
P/TBV Ratio
--1.671.122.12-
Upgrade
EV/Sales Ratio
7.542.952.59-15.2614.39
Upgrade
Debt / Equity Ratio
-10.52-10.520.350.010.022.22
Upgrade
Asset Turnover
0.170.170.090.040.050.07
Upgrade
Inventory Turnover
1.881.881.371.241.441.87
Upgrade
Quick Ratio
0.410.412.295.778.810.10
Upgrade
Current Ratio
0.620.622.556.029.090.16
Upgrade
Return on Equity (ROE)
-269.18%-269.18%-93.11%-82.98%-91.62%-373.13%
Upgrade
Return on Assets (ROA)
-70.52%-70.52%-43.34%-27.46%-29.63%-44.04%
Upgrade
Return on Capital (ROIC)
-104.73%-104.73%-52.61%-30.25%-33.91%-61.74%
Upgrade
Earnings Yield
-116.72%-231.65%-104.61%-106.59%-31.49%-199.94%
Upgrade
FCF Yield
-110.27%-218.87%-100.73%-52.97%-21.02%-96.99%
Upgrade
Buyback Yield / Dilution
-35.84%-35.84%-8.92%-34.34%-359.21%-316.36%
Upgrade
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q